Ocular Therapeutix, Inc
OCUL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001393434
In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Ocular Therapeutix, Inc as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 271
- +29 vs. Q4 2025
- Shares held
- 207.2M
- +27.3M (+15.2%) vs. Q4 2025
- Total value
- $1.77B
- −$414.3M (−19.0%) vs. Q4 2025
- New holders
- 79
- 104 more added
- Sold out
- 50
- 59 more reduced
7 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OCUL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 262 | $2.03B |
| Q1 2026 | 271 | $1.77B |
| Q4 2025 | 249 | $2.33B |
| Q3 2025 | 216 | $2.20B |
| Q2 2025 | 187 | $1.45B |
| Q1 2025 | 197 | $1.01B |
| Q4 2024 | 180 | $1.14B |
| Q3 2024 | 168 | $1.22B |
| Q2 2024 | 151 | $939.8M |
| Q1 2024 | 147 | $1.12B |
| Q4 2023 | 119 | $328.8M |
| Q3 2023 | 114 | $127.0M |
| Q2 2023 | 135 | $224.2M |
| Q1 2023 | 127 | $213.8M |
| Q4 2022 | 116 | $111.3M |
| Q3 2022 | 130 | $177.6M |
| Q2 2022 | 123 | $178.2M |
| Q1 2022 | 132 | $215.4M |
| Q4 2021 | 140 | $289.1M |
| Q3 2021 | 141 | $445.7M |
| Q2 2021 | 149 | $685.8M |
| Q1 2021 | 154 | $774.9M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Ocular Therapeutix, Inc; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cerity Partners LLC | 0 | $0 | 0.00% | −25,406−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −25,116−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −23,984−100.0% | Sold out |
| Voleon Capital Management LP | 0 | $0 | 0.00% | −21,822−100.0% | Sold out |
| Contravisory Investment Management, Inc. | 0 | $0 | 0.00% | −21,241−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −18,165−100.0% | Sold out |
| Caxton Associates LLP | 0 | $0 | 0.00% | −17,932−100.0% | Sold out |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −14,855−100.0% | Sold out |
| RWC Asset Management LLP | 0 | $0 | 0.00% | −14,797−100.0% | Sold out |
| Fifth Lane Capital, LP | 0 | $0 | 0.00% | −14,358−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −12,364−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −10,903−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −6,403−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −5,846−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −2,687−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −710−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −535−100.0% | Sold out |
| Key Financial Inc | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Chilton Capital Management LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| TD Capital Management LLC | 0 | $0 | 0.00% | −47−100.0% | Sold out |
| Bare Financial Services, Inc | 0 | $0 | 0.00% | −41−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Norges Bank | – | – | – | – | Not filed |
| CIBC World Markets Corp | – | – | – | – | Not filed |
| Sherbrooke Park Advisers LLC | – | – | – | – | Not filed |
| Trust Co of Vermont | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |